1,504 karma · joined June 1, 2015
Mission: To measure and honor the value of every individual.
Vision: Corporations and Individuals providing value directly for each other.
Product: A URL shortening service for individuals to monetize the content they share. Monetization occurs via an ad featured between the platform sharing the short url (e.g. Facebook) and the site the short url takes the user to (the content being shared).
The team right now is investing itself in areas such product, marketing, and architecture. We want to launch a product so we can begin testing our hypotheses, but we also want to go to battle sufficiently prepared. The latter requires significant effort in team building, which would detract from a product launch. What should we do?
[1] http://mason.gmu.edu/~rhanson/futarchy.html [2] http://www.augur.net/
The intended effect is that books with more pages will receive more payout (assuming they're actually being read).
There was a pretty good discussion on this particular thread: https://news.ycombinator.com/item?id=3173993
This is one way of functioning. There is, however, another approach. It's called the Blue Ocean Strategy. Here's an excerpt from the wikipedia page [1]:
Unlike the “Red Ocean Strategy”, the conventional approach to business of beating competition derived from the military organization, the “Blue Ocean Strategy” tries to align innovation with utility, price and cost positions.
https://developer.mozilla.org/en-US/docs/Web/API/Window/setI...
- Use a CDN to serve static content without the need to serve the content out of the origin server every request.
- Create instances of your application in multiple regions. The shortest path to your web app varies based on where the user is in the world. Multiple regions can minimize the latency introduced via the hops s/he must make.
"setTimeout and browser timing are deceptive and shouldn’t be wholly trusted"... and as a result, use the setImmediate API.
Big Pharma companies drive drug development in the first place, so obstructing the benzo revenue without a suitable alternative may lead to better drugs taking longer to develop. I'm assuming the non-benzos (SSRIs like Lexapro) aren't functionally equivalent to the benzos in how they "help" patients, by some measure that is unknown to me.
GitHub Page with a write-up of the actual Sidechain Elements: http://elementsproject.org/
"...the agency had breached its own privacy rules or overstepped its legal authority thousands of times a year since 2008."
"Mr. Snowden committed very serious crimes... that he should face."